Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LRE

Cryo-EM of the SLFN12-PDE3A complex: SLFN12 body refinement

Summary for 7LRE
Entry DOI10.2210/pdb7lre/pdb
Related7LRC 7LRD
EMDB information23496
DescriptorSchlafen family member 12, ZINC ION (2 entities in total)
Functional Keywordscomplex, velcrin, molecular glue, dnmdp, rna binding protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight134898.29
Authors
Fuller, J.R.,Garvie, C.W.,Lemke, C.T. (deposition date: 2021-02-16, release date: 2021-06-09, Last modification date: 2024-03-06)
Primary citationGarvie, C.W.,Wu, X.,Papanastasiou, M.,Lee, S.,Fuller, J.,Schnitzler, G.R.,Horner, S.W.,Baker, A.,Zhang, T.,Mullahoo, J.P.,Westlake, L.,Hoyt, S.H.,Toetzl, M.,Ranaghan, M.J.,de Waal, L.,McGaunn, J.,Kaplan, B.,Piccioni, F.,Yang, X.,Lange, M.,Tersteegen, A.,Raymond, D.,Lewis, T.A.,Carr, S.A.,Cherniack, A.D.,Lemke, C.T.,Meyerson, M.,Greulich, H.
Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.
Nat Commun, 12:4375-4375, 2021
Cited by
PubMed Abstract: DNMDP and related compounds, or velcrins, induce complex formation between the phosphodiesterase PDE3A and the SLFN12 protein, leading to a cytotoxic response in cancer cells that express elevated levels of both proteins. The mechanisms by which velcrins induce complex formation, and how the PDE3A-SLFN12 complex causes cancer cell death, are not fully understood. Here, we show that PDE3A and SLFN12 form a heterotetramer stabilized by binding of DNMDP. Interactions between the C-terminal alpha helix of SLFN12 and residues near the active site of PDE3A are required for complex formation, and are further stabilized by interactions between SLFN12 and DNMDP. Moreover, we demonstrate that SLFN12 is an RNase, that PDE3A binding increases SLFN12 RNase activity, and that SLFN12 RNase activity is required for DNMDP response. This new mechanistic understanding will facilitate development of velcrin compounds into new cancer therapies.
PubMed: 34272366
DOI: 10.1038/s41467-021-24495-w
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.76 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon